Evidence map›Paper›PMID 41266544›Full record

ArticleScientific reports2025

Mapping real-time metabolic kinetics of expanded CAR T cells using hyperpolarized

Thomas B Wareham Mathiassen, Mikkel Rasmus Hansen, Magnus Karlsson, Sine Reker Hadrup, Maria Ormhøj, Pernille Rose Jensen

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thomas B Wareham Mathiassen *Section for Magnetic Resonance, Department of Health Technology, Technical University of Denmark, 2800 Kgs., Lyngby, Denmark.
Mikkel Rasmus Hansen *Section for Experimental and Translational Immunology (xTI), Department of Health Technology, Technical University of Denmark, 2800 Kgs., Lyngby, Denmark.
Magnus KarlssonSection for Magnetic Resonance, Department of Health Technology, Technical University of Denmark, 2800 Kgs., Lyngby, Denmark.
Sine Reker HadrupSection for Experimental and Translational Immunology (xTI), Department of Health Technology, Technical University of Denmark, 2800 Kgs., Lyngby, Denmark.
Maria OrmhøjSection for Experimental and Translational Immunology (xTI), Department of Health Technology, Technical University of Denmark, 2800 Kgs., Lyngby, Denmark. maor@igt.sdu.dk.
Pernille Rose JensenSection for Magnetic Resonance, Department of Health Technology, Technical University of Denmark, 2800 Kgs., Lyngby, Denmark. peroje@dtu.dk.

Funding

Carlsbergfondet CF21-0480Danmarks Grundforskningsfond DNRF124Independent Research Fond Denmark 0129-00005BNovo Nordisk Fonden NNF19OC0055825
6 · The paper itself

Abstract

Chimeric Antigen Receptor (CAR) T cell therapy has advanced cancer treatment, providing options for patients with refractory hematological malignancies. Understanding the metabolic changes in CAR T cells during their activation, proliferation, and therapeutic application is essential for improving efficacy. In this study, human CD19 CAR T cells were expanded from three healthy donors under a standard manufacturing protocol. Hyperpolarized

Indexed as

GlucoseMetabolomicsReceptors, Chimeric AntigenT-LymphocytesCarbon IsotopesGlycolysisHumansImmunotherapy, AdoptiveKineticsMagnetic Resonance SpectroscopyOxidative PhosphorylationCarbon-13Carbon IsotopesGlucoseReceptors, Chimeric AntigenCAR T cellsdDNP-NMRImmunotherapyMetabolismNMR spectroscopy

Identifiers

PMID41266544
PMCPMC12635404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.